← Open Payments lookup

MICHAEL WRIGHT: Open Payments

NPI 1174753453 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$674 in 29 payments from 12 companies in 2025. Trend: 2023 $534 · 2024 $213 · 2025 $674

Food & beverage: $674
CompanyPaymentsAmount
Axsome Therapeutics, Inc.3$145
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$145
Alkermes, Inc.4$71
ABBVIE INC.3$52
Neurocrine BioSciences, Inc.2$48
Janssen Pharmaceuticals, Inc2$45
Supernus Pharmaceuticals, Inc.2$43
E.R. Squibb & Sons, L.L.C.2$38
Teva Pharmaceuticals USA, Inc.2$31
Noven Therapeutics, LLC1$21

Products named: Auvelity, CAPLYTA, ARISTADA, VRAYLAR, INGREZZA, INVEGA SUSTENNA, Qelbree, COBENFY.

Industry payments across LA — which companies pay providers there.